These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 28441965)

  • 21. Norovirus P particle: an excellent vaccine platform for antibody production against Alzheimer's disease.
    Fu L; Li Y; Hu Y; Yu B; Zhang H; Wu J; Wu H; Yu X; Kong W
    Immunol Lett; 2015 Nov; 168(1):22-30. PubMed ID: 26349054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel Abeta immunogens: is shorter better?
    Lemere CA; Maier M; Peng Y; Jiang L; Seabrook TJ
    Curr Alzheimer Res; 2007 Sep; 4(4):427-36. PubMed ID: 17908047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates.
    McCluskie MJ; Brazolot Millan CL; Gramzinski RA; Robinson HL; Santoro JC; Fuller JT; Widera G; Haynes JR; Purcell RH; Davis HL
    Mol Med; 1999 May; 5(5):287-300. PubMed ID: 10390545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-immunization with DNA and protein mixture: a safe and efficacious immunotherapeutic strategy for Alzheimer's disease in PDAPP mice.
    Liu S; Shi D; Wang HC; Yu YZ; Xu Q; Sun ZW
    Sci Rep; 2015 Jan; 5():7771. PubMed ID: 25586780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA Aβ42 immunization via needle-less Jet injection in mice and rabbits as potential immunotherapy for Alzheimer's disease.
    Lambracht-Washington D; Fu M; Wight-Carter M; Riegel M; Hynan LS; Rosenberg RN
    J Neurol Sci; 2023 Mar; 446():120564. PubMed ID: 36731358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Japanese encephalitis virus DNA vaccine candidates in rhesus monkeys [Macaca mulatta].
    Bharati K; Rani R; Vrati S
    Vaccine; 2009 Jan; 27(1):10-6. PubMed ID: 18996161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mapping of immune responses following wild-type and mutant ABeta42 plasmid or peptide vaccination in different mouse haplotypes and HLA Class II transgenic mice.
    Kutzler MA; Cao C; Bai Y; Dong H; Choe PY; Saulino V; McLaughlin L; Whelan A; Choo AY; Weiner DB; Ugen KE
    Vaccine; 2006 May; 24(21):4630-9. PubMed ID: 16157426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
    Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
    Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Active immunization with the peptide epitope vaccine Aβ3-10-KLH induces a Th2-polarized anti-Aβ antibody response and decreases amyloid plaques in APP/PS1 transgenic mice.
    Ding L; Meng Y; Zhang HY; Yin WC; Yan Y; Cao YP
    Neurosci Lett; 2016 Nov; 634():1-6. PubMed ID: 27693663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific humoral immune responses in rhesus monkeys vaccinated with the Alzheimer's disease-associated beta-amyloid 1-15 peptide vaccine.
    Li SB; Wang HQ; Lin X; Xu J; Xie Y; Yuan QF; Yao ZB
    Chin Med J (Engl); 2005 Apr; 118(8):660-4. PubMed ID: 15899121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maysin and Its Flavonoid Derivative from Centipedegrass Attenuates Amyloid Plaques by Inducting Humoral Immune Response with Th2 Skewed Cytokine Response in the Tg (APPswe, PS1dE9) Alzheimer's Mouse Model.
    Song Y; Kim HD; Lee MK; Hong IH; Won CK; Bai HW; Lee SS; Lee S; Chung BY; Cho JH
    PLoS One; 2017; 12(1):e0169509. PubMed ID: 28072821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strikingly reduced amyloid burden and improved behavioral performance in Alzheimer's disease mice immunized with recombinant chimeric vaccines by hexavalent foldable Aβ₁₋₁₅ fused to toxin-derived carrier proteins.
    Yu YZ; Wang WB; Chen A; Chang Q; Liu S; Zhao M; Wang S; Qiu WY; Pang XB; Xu Q; Sun ZW
    J Alzheimers Dis; 2014; 41(1):243-60. PubMed ID: 24625800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies from a DNA peptide vaccination decrease the brain amyloid burden in a mouse model of Alzheimer's disease.
    Schiltz JG; Salzer U; Mohajeri MH; Franke D; Heinrich J; Pavlovic J; Wollmer MA; Nitsch RM; Moelling K
    J Mol Med (Berl); 2004 Oct; 82(10):706-14. PubMed ID: 15241501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of three plasmid systems for use in DNA A beta 42 immunization as therapy for Alzheimer's disease.
    Qu BX; Lambracht-Washington D; Fu M; Eagar TN; Stüve O; Rosenberg RN
    Vaccine; 2010 Jul; 28(32):5280-7. PubMed ID: 20562015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Co-stimulation with TNF receptor superfamily 4/25 antibodies enhances in-vivo expansion of CD4+CD25+Foxp3+ T cells (Tregs) in a mouse study for active DNA Aβ42 immunotherapy.
    Lambracht-Washington D; Rosenberg RN
    J Neuroimmunol; 2015 Jan; 278():90-9. PubMed ID: 25595257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age-related differences in the immune response to immunization with human Abeta42 peptide.
    Pifer J; Hennes JL; Lee JM; Witte PL
    J Gerontol A Biol Sci Med Sci; 2002 Oct; 57(10):B355-8. PubMed ID: 12242310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peripherally administered sera antibodies recognizing amyloid-β oligomers mitigate Alzheimer's disease-like pathology and cognitive decline in aged 3× Tg-AD mice.
    Wang HC; Yu YZ; Liu S; Zhao M; Xu Q
    Vaccine; 2016 Apr; 34(15):1758-66. PubMed ID: 26945100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunization with Small Amyloid-β-derived Cyclopeptide Conjugates Diminishes Amyloid-β-Induced Neurodegeneration in Mice.
    Mulder CK; Dong Y; Brugghe HF; Timmermans HA; Tilstra W; Westdijk J; van Riet E; van Steeg H; Hoogerhout P; Eisel UL
    J Alzheimers Dis; 2016; 52(3):1111-23. PubMed ID: 27060957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies.
    Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Logroscino G; Santamato A; Greco A; Seripa D; Pilotto A
    Immunotherapy; 2012 Feb; 4(2):213-38. PubMed ID: 22339463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Passive immunization of the Abeta42(43) C-terminal-specific antibody BC05 in a mouse model of Alzheimer's disease.
    Asami-Odaka A; Obayashi-Adachi Y; Matsumoto Y; Takahashi H; Fukumoto H; Horiguchi T; Suzuki N; Shoji M
    Neurodegener Dis; 2005; 2(1):36-43. PubMed ID: 16909001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.